ELV - Elevance Health Inc.
NEXT EARNINGS:
Apr 22, 2026
EPS Est: $10.55
|
Rev Est: $48.5B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$387.14
DETAILS
HIGH:
$425.00
LOW:
$332.00
MEDIAN:
$394.50
CONSENSUS:
$387.14
UPSIDE:
18.34%
Market Cap:
72.20B
Volume:
771,129
Avg Volume:
1,616,280
52 Week Range:
273.71-458.75
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Beta:
0.50
Last Dividend:
$6.84
Exchange:
NYSE
Country:
US
Employees:
104,200
IPO Date:
2001-10-30
EPS (TTM):
25.18
P/E Ratio:
13.73
Revenue (TTM):
199.12B
Total Assets:
121.49B
Total Debt:
33.23B
Cash & Equiv:
9.49B
Rev Growth (5Y):
10.3%
EPS Growth (5Y):
6.7%
FCF Growth (5Y):
-20.0%
ROCE:
8.0%
Debt/Equity:
0.76
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-28 | $3.33 | $3.10 | +7.4% | $49.7B | $49.8B | -0.2% |
| 2025-10-21 | $6.03 | $4.93 | +22.3% | $50.7B | $49.4B | +2.7% |
| 2025-07-17 | $8.84 | $8.91 | -0.8% | $49.8B | $48.2B | +3.3% |
| 2025-04-22 | $11.97 | $11.41 | +4.9% | $48.9B | $46.3B | +5.6% |
| 2025-01-23 | $3.84 | $3.80 | +1.1% | $45.4B | $45.0B | +1.1% |
| 2024-10-17 | $8.37 | $9.66 | -13.4% | $45.1B | $43.5B | +3.9% |
| 2024-07-17 | $10.12 | $10.01 | +1.1% | $43.6B | $43.0B | +1.5% |
| 2024-04-18 | $10.64 | $10.53 | +1.0% | $42.6B | $42.5B | +0.2% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 199.12B | 176.81B | 171.34B | 156.59B | 138.64B | 121.87B | 104.21B | 92.11B | 90.04B | 84.86B | 79.16B | 73.87B |
| Net Income | 5.66B | 5.98B | 5.99B | 5.89B | 6.16B | 4.57B | 4.81B | 3.75B | 3.84B | 2.47B | 2.56B | 2.57B |
| EPS | 25.18 | 25.81 | 25.38 | 24.56 | 25.25 | 18.23 | 18.81 | 14.53 | 14.70 | 9.39 | 9.73 | 9.31 |
| Total Assets | 121.49B | 116.89B | 108.93B | 102.75B | 97.46B | 86.61B | 77.45B | 71.57B | 70.54B | 65.08B | 61.72B | 61.68B |
| Total Debt | 33.23B | 31.23B | 25.12B | 24.11B | 23.03B | 20.04B | 20.09B | 19.21B | 19.93B | 15.73B | 15.86B | 15.04B |
| Cash & Equivalents | 9.49B | 8.29B | 6.53B | 7.39B | 4.88B | 5.74B | 4.94B | 3.93B | 3.61B | 4.08B | 2.11B | 2.15B |
| Operating Cash Flow | 4.29B | 5.81B | 8.06B | 8.40B | 8.36B | 10.69B | 6.06B | 3.83B | 4.18B | 3.20B | 4.12B | 3.37B |
| Free Cash Flow | 3.17B | 4.55B | 6.76B | 7.25B | 7.28B | 9.67B | 4.98B | 2.62B | 3.39B | 2.62B | 3.51B | 2.74B |
| FCF per Share | 14.31 | 19.55 | 29.03 | 30.20 | 29.85 | 38.54 | 19.51 | 10.30 | 13.26 | 9.94 | 13.45 | 10.23 |
| Book Value | 43.88B | 41.31B | 39.31B | 36.24B | 36.06B | 33.20B | 31.73B | 28.54B | 26.50B | 25.10B | 23.04B | 24.25B |
| Cash & ST Investments | 9.49B | 33.49B | 36.14B | 33.34B | 31.15B | 29.17B | 24.61B | 20.65B | 21.00B | 21.25B | 19.05B | 19.64B |
| ROC Equity | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.14 | 0.15 | 0.13 | 0.15 | 0.10 | 0.11 | 0.11 |